PSYCHEMEDICS CORPORATION — Revenue by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6c9eeeaf-67ee-4ed6-ad10-0f39a7b10c2a/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $19.7M | 2024-01-01 – 2024-12-31 | evidence 0001171843-25-001658 |
| FY 2023 | $22.1M | 2023-01-01 – 2023-12-31 | evidence 0001171843-24-001671 |
| FY 2022 | $25.2M | 2022-01-01 – 2022-12-31 | evidence 0001171843-23-001908 |
| FY 2021 | $24.9M | 2021-01-01 – 2021-12-31 | evidence 0001171843-22-002192 |
| FY 2020 | $21.4M | 2020-01-01 – 2020-12-31 | evidence 0001171843-21-002107 |
| FY 2019 | $37.7M | 2019-01-01 – 2019-12-31 | evidence 0001171843-20-001248 |
| FY 2018 | $42.7M | 2018-01-01 – 2018-12-31 | evidence 0001171843-19-001481 |
| FY 2017 | $39.7M | 2017-01-01 – 2017-12-31 | evidence 0001171843-19-001481 |
| FY 2016 | $39.0M | 2016-01-01 – 2016-12-31 | evidence 0001171843-19-001481 |
| FY 2015 | $27.0M | 2015-01-01 – 2015-12-31 | evidence 0001144204-17-013217 |
| FY 2014 | $29.2M | 2014-01-01 – 2014-12-31 | evidence 0001144204-17-013217 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PSYCHEMEDICS CORPORATION — all facts · Net Income · Operating Income